Laporan Laba Rugi (TTM)
Laporan Laba Rugi Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,221,804 | 3,199,240 | 3,197,812 | 3,345,565 | 3,401,450 | 3,465,991 | 3,569,006 | 3,591,868 | 3,749,354 | 3,944,611 | 4,027,478 | 4,113,631 | 4,154,414 | 4,169,049 | 4,263,762 | 4,413,134 | 4,546,083 | 4,579,021 | 4,581,551 | 4,480,246 |
| Change (%) | -0.70 | -0.04 | 4.62 | 1.67 | 1.90 | 2.97 | 0.64 | 4.38 | 5.21 | 2.10 | 2.14 | 0.99 | 0.35 | 2.27 | 3.50 | 3.01 | 0.72 | 0.06 | -2.21 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,144,622 | 1,152,572 | 1,013,655 | 1,017,765 | 1,046,428 | 1,072,174 | 1,127,308 | 1,178,926 | 1,203,467 | 1,269,731 | 1,253,163 | 1,281,395 | 1,319,532 | 1,344,056 | 1,431,505 | 1,497,345 | 1,548,074 | 1,585,467 | 1,571,419 | 1,569,140 |
| Change (%) | 0.69 | -12.05 | 0.41 | 2.82 | 2.46 | 5.14 | 4.58 | 2.08 | 5.51 | -1.30 | 2.25 | 2.98 | 1.86 | 6.51 | 4.60 | 3.39 | 2.42 | -0.89 | -0.15 | |
| % of Revenue | 35.53 | 36.03 | 31.70 | 30.42 | 30.76 | 30.93 | 31.59 | 32.82 | 32.10 | 32.19 | 31.12 | 31.15 | 31.76 | 32.24 | 33.57 | 33.93 | 34.05 | 34.62 | 34.30 | 35.02 |
| Gross Operating Profit | 2,077,182 | 2,046,668 | 2,184,157 | 2,327,800 | 2,355,022 | 2,393,817 | 2,441,698 | 2,412,942 | 2,545,887 | 2,674,880 | 2,774,315 | 2,832,236 | 2,834,882 | 2,824,993 | 2,837,084 | 2,915,789 | 2,998,009 | 2,993,554 | 3,010,132 | 2,911,106 |
| Change (%) | -1.47 | 6.72 | 6.58 | 1.17 | 1.65 | 2.00 | -1.18 | 5.51 | 5.07 | 3.72 | 2.09 | 0.09 | -0.35 | 0.43 | 2.77 | 2.82 | -0.15 | 0.55 | -3.29 | |
| % of Revenue | 64.47 | 63.97 | 68.30 | 69.58 | 69.24 | 69.07 | 68.41 | 67.18 | 67.90 | 67.81 | 68.88 | 68.85 | 68.24 | 67.76 | 66.54 | 66.07 | 65.95 | 65.38 | 65.70 | 64.98 |
| SG&A | 921,830 | 895,464 | 875,514 | 892,983 | 888,737 | 897,171 | 886,327 | 897,964 | 934,687 | 965,908 | 997,234 | 1,013,867 | 1,018,085 | 1,023,306 | 1,053,819 | 1,075,736 | 1,091,066 | 1,094,134 | 1,104,732 | 1,090,587 |
| Change (%) | -2.86 | -2.23 | 2.00 | -0.48 | 0.95 | -1.21 | 1.31 | 4.09 | 3.34 | 3.24 | 1.67 | 0.42 | 0.51 | 2.98 | 2.08 | 1.43 | 0.28 | 0.97 | -1.28 | |
| % of Revenue | 28.61 | 27.99 | 27.38 | 26.69 | 26.13 | 25.88 | 24.83 | 25.00 | 24.93 | 24.49 | 24.76 | 24.65 | 24.51 | 24.55 | 24.72 | 24.38 | 24.00 | 23.89 | 24.11 | 24.34 |
| R&D | 491,903 | 486,660 | 455,765 | 471,424 | 484,868 | 495,680 | 526,087 | 547,214 | 569,758 | 616,009 | 633,325 | 652,459 | 682,260 | 695,012 | 729,924 | 734,339 | 725,957 | 708,769 | 730,226 | 705,654 |
| Change (%) | -1.07 | -6.35 | 3.44 | 2.85 | 2.23 | 6.13 | 4.02 | 4.12 | 8.12 | 2.81 | 3.02 | 4.57 | 1.87 | 5.02 | 0.60 | -1.14 | -2.37 | 3.03 | -3.36 | |
| % of Revenue | 15.27 | 15.21 | 14.25 | 14.09 | 14.25 | 14.30 | 14.74 | 15.23 | 15.20 | 15.62 | 15.73 | 15.86 | 16.42 | 16.67 | 17.12 | 16.64 | 15.97 | 15.48 | 15.94 | 15.75 |
| OpEx | 3,002,663 | 2,957,560 | 2,773,765 | 2,824,862 | 2,832,485 | 2,890,306 | 2,968,944 | 3,075,657 | 3,220,897 | 3,383,730 | 3,407,811 | 3,483,947 | 3,576,755 | 3,688,323 | 3,899,669 | 3,897,902 | 3,892,458 | 3,989,309 | 4,018,615 | 3,920,973 |
| Change (%) | -1.50 | -6.21 | 1.84 | 0.27 | 2.04 | 2.72 | 3.59 | 4.72 | 5.06 | 0.71 | 2.23 | 2.66 | 3.12 | 5.73 | -0.05 | -0.14 | 2.49 | 0.73 | -2.43 | |
| % of Revenue | 93.20 | 92.45 | 86.74 | 84.44 | 83.27 | 83.39 | 83.19 | 85.63 | 85.91 | 85.78 | 84.61 | 84.69 | 86.10 | 88.47 | 91.46 | 88.33 | 85.62 | 87.12 | 87.71 | 87.52 |
| Operating Income | 219,141 | 241,680 | 424,047 | 520,703 | 568,965 | 575,685 | 600,062 | 516,211 | 528,457 | 560,881 | 619,667 | 629,684 | 577,659 | 480,726 | 499,475 | 515,232 | 653,625 | 589,712 | 562,936 | 559,273 |
| Change (%) | 10.29 | 75.46 | 22.79 | 9.27 | 1.18 | 4.23 | -13.97 | 2.37 | 6.14 | 10.48 | 1.62 | -8.26 | -16.78 | 3.90 | 3.15 | 26.86 | -9.78 | -4.54 | -0.65 | |
| % of Revenue | 6.80 | 7.55 | 13.26 | 15.56 | 16.73 | 16.61 | 16.81 | 14.37 | 14.09 | 14.22 | 15.39 | 15.31 | 13.90 | 11.53 | 11.71 | 11.67 | 14.38 | 12.88 | 12.29 | 12.48 |
| Interest Expense | -172,362 | -214,444 | -130,806 | -155,028 | -125,026 | -113,884 | -122,432 | -106,833 | -126,764 | -105,658 | -116,973 | -143,248 | -159,410 | -166,119 | -115,392 | -115,392 | -119,122 | -89,738 | -130,487 | -133,087 |
| Change (%) | 24.41 | -39.00 | 18.52 | -19.35 | -8.91 | 7.51 | -12.74 | 18.66 | -16.65 | 10.71 | 22.46 | 11.28 | 4.21 | -30.54 | -0.00 | 3.23 | -24.67 | 45.41 | 1.99 | |
| % of Revenue | -5.35 | -6.70 | -4.09 | -4.63 | -3.68 | -3.29 | -3.43 | -2.97 | -3.38 | -2.68 | -2.90 | -3.48 | -3.84 | -3.98 | -2.71 | -2.61 | -2.62 | -1.96 | -2.85 | -2.97 |
| Net Income | 56,051 | 180,631 | 376,005 | 431,178 | 473,105 | 438,515 | 230,059 | 197,389 | 213,167 | 274,525 | 317,017 | 301,398 | 191,626 | 178,219 | 144,067 | 149,920 | 289,996 | 208,065 | 107,928 | 136,923 |
| Change (%) | 222.26 | 108.16 | 14.67 | 9.72 | -7.31 | -47.54 | -14.20 | 7.99 | 28.78 | 15.48 | -4.93 | -36.42 | -7.00 | -19.16 | 4.06 | 93.43 | -28.25 | -48.13 | 26.87 | |
| % of Revenue | 1.74 | 5.65 | 11.76 | 12.89 | 13.91 | 12.65 | 6.45 | 5.50 | 5.69 | 6.96 | 7.87 | 7.33 | 4.61 | 4.27 | 3.38 | 3.40 | 6.38 | 4.54 | 2.36 | 3.06 |
Source: Capital IQ
